Current research has shown the relevance of this pathway to aging and, coupled with AD, can alter normal AKT and mTOR activity since both are controlled by oxidative stress, decreased nutrient concentration, and innate immune signals. This evidence concerns the gene AKT1 and Alzheimer disease.